Patent directory · USPTO A61K / A61P
Patents matching “SION”
1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
WO 2026106858
FORMULATIONS ET PROCÉDÉS POUR MAINTENIR UNE SUSPENSION ET UNE VIABILITÉ DE CELLULES
granted -
US 20260108463
NANOEMULSION FORMULATION WITH IMPROVED TACROLIMUS STABILITY AND SKIN PENETRATION
granted -
US 20260096994
SOLID DISPERSIONS HAVING STABILIZED EMULSION PARTICLES
granted -
WO 2026033885
POLYTHÉRAPIE FAISANT INTERVENIR DES AGENTS DE LIAISON BISPÉCIFIQUES SE LIANT À CLDN18.2 ET CD3 ET AGENTS STABILISANT OU AUGMENTANT L'EXPRESSION DE CLDN18.2
granted -
WO 2026024938
MÉTHODES DE RÉDUCTION DE LA TRANSMISSION INTRA-UTÉRINE D'UNE INFECTION À SALMONELLA DUBLIN
granted -
WO 2026015429
BONBONS GOMMEUX À COMPRESSION DIRECTE
granted -
WO 2025260042
CONSTRUCTIONS D'ARNI ET PROCÉDÉS D'INHIBITION DE L'EXPRESSION DE CNR1
granted -
WO 2025252204
DISPERSIONS SOLIDES AMORPHES D'UN INHIBITEUR DE BRAF
granted -
WO 2025242583
NOUVELLE FORMULATION COMPRENANT DE L'ÉLINZANÉTANT DANS UNE DISPERSION SOLIDE
granted -
WO 2025233516
MÉTHODE D'AUGMENTATION DU TEMPS JUSQU'À LA DEUXIÈME PROGRESSION ET DU TEMPS JUSQU'À LA PREMIÈRE CHIMIOTHÉRAPIE SUIVANTE
granted -
US 12419920
Bifidobacterium longum NCIMB 41676
granted -
US 12415843
Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for the treatment of cancer
granted -
US 12409188
Modulators of HSD17B13 expression
granted -
US 12410418
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
granted -
US 12410430
Modulating apolipoprotein (A) expression
granted -
US 12404313
GDNF fusion polypeptides and methods of use thereof
granted -
US 12404297
Salts and crystal forms of GABA-A positive allosteric modulator
granted -
US 12403192
Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
granted -
US 12404497
Uses and methods for oncolytic virus targeting of IL-4/IL-13 and fusions thereof
granted -
US 12396988
Methods of using muscarinic antagonists in the treatment of depression
granted -
US 12390509
Pharmaceutical composition comprising frataxin fusion protein and methods of use thereof
granted -
US 12383516
Albuterol aerosol suspension formulation for oral inhalation with high amount of green propellant hydrofluoroolefin (HFO) and free of co-solvent
granted -
US 12383618
Expression vector delivery system and use thereof for inducing an immune response
granted -
US 12383566
Inhibition of SLC transporter activity or expression to attenuate anthracycline-induced cardiotoxicity
granted